Twitter Twitter Facebook Facebook Linked In Linked In Zone In Zone In Google Plus Zone In

Research Update

Unexpected In Vivo Toxicity Supports Use of mRNA in CAR T-Cell Therapy

Researchers at Oslo University have discovered an important finding that may change the way scientists design certain types of T-cell therapies. T cells play a key role in cell-mediated immunity and in recent years scientists have learned how to isolate a patient’s own T cells, engineer the receptors to attack specific cells, such as cancer cells, and reintroduce them back into the patient.

The team, led by Jon Kyte, has been working on a T-cell therapy platform that utilizes transient expression of chimeric antigen receptors (CARs) to target leukemia and other blood-related cancers.

Read More

Come and See our Poster
Next Generation DX Aug 18-20 Washington DC

Featured Product
Want to evade the immune system? Try our Immune Stimulation Reduction Transcription Nucleotide Set and save 10%!

mRNA Data Gallery
Explore the latest data from our customers and collaborators
mRNA Vaccine and Immunotherapy Development from Concept to Clinic

% Antigen Specific CD8 T Cells
We know that each stage of vaccine and immunotherapy research has different needs and budgets. That?s why we offer:
Coming Soon: Stocked TRP-2 mRNA and gp100 mRNA


Vaccination with OVA mRNA(L-6328; L-6128) resulted in a high number of antigen specific CD8 T cells. See more data and full experimental details here.
Ask an Expert

What are the benefits of using mRNA over plasmid or viral-based approaches for vaccine and immunotherapy development?

mRNA offers several advantages over traditional plasmid and viral-based approaches: First, mRNA boasts a superior safety profile. As a transient carrier of genetic information, it is metabolized naturally and poses little to no risk of genomic integration.

Read More

Zone in with Zon Blog Post

RNA in DNA?Mistake or Mystery?

  • Human DNA Misincorporates >1 mil Ribonucleotides Per Replication Cycle
  • These Mistakes are Likely Biological Mysteries
  • Four New Sequencing Methods May Demystify Why There?s ?R in DNA?
Read More


© 2015 TriLink BioTechnologies, Inc. | All Rights Reserved